SCHEMBL740174

SCHEMBL740174

COCCCn1c(C2CCCN(C(=O)[C@@H]3CN(C(=O)c4cccc(OC)c4)C[C@H]3N)C2)nc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 5/20 0.47
HRH1 P35367 5/20 0.47
CYP2D6 P10635 2/20 0.47
CHRM1 P11229 1/20 0.46
DPP4 P27487 3/20 0.44
DPP8 Q6V1X1 2/20 0.44
UBE2M P61081 1/20 0.43
DCUN1D1 Q96GG9 1/20 0.43
PROKR1 Q8TCW9 1/20 0.42
ADORA2A P29274 3/20 0.41
PDE2A O00408 2/20 0.41
CNR2 P34972 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
PDE3A Q14432 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740173 1.00 KCNH2 (0.47) KCNH2HRH1CYP2D6CHRM1DPP4
SCHEMBL739316 0.94 HRH1 (0.47) KCNH2HRH1CYP2D6CHRM1DPP4
SCHEMBL739317 0.94 HRH1 (0.47) KCNH2HRH1CYP2D6CHRM1DPP4
SCHEMBL739483 0.92 CNR2 (0.48) KCNH2HRH1CYP2D6CHRM1DPP4
SCHEMBL739481 0.92 CNR2 (0.48) KCNH2HRH1CYP2D6CHRM1DPP4
SCHEMBL738833 0.92 HRH1 (0.49) KCNH2HRH1CYP2D6CHRM1DPP4
SCHEMBL738834 0.92 HRH1 (0.49) KCNH2HRH1CYP2D6CHRM1DPP4
SCHEMBL740493 0.92 OPRK1 (0.43) KCNH2HRH1CYP2D6CHRM1DPP4
SCHEMBL742023 0.92 DPP4 (0.43) KCNH2HRH1CYP2D6CHRM1DPP4
SCHEMBL740538 0.92 HRH1 (0.43) KCNH2HRH1CYP2D6CHRM1DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US claimed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed